StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

COSCIENS Biopharma's price to sales ratio was 2.7× on Oct 19, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 64.3×, with a median of 2.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20262.7×+2.0
2025Dec 31, 20250.7×−0.1
2024Dec 31, 20240.8×−17.3
2023Jan 31, 202318.1×+3.1
2022Dec 30, 202215.0×−6.6
2021Dec 31, 202121.6×−18.5
2020Dec 31, 202040.1×+7.3
2019Dec 31, 201932.8×−157.8
2018Dec 31, 2018190.6×+83.4
2017Dec 29, 2017107.2×+34.2
2016Dec 30, 201673.0×–

More COSCIENS Biopharma figures

See a number that looks wrong?